Dates to Remember

AMP 2010 Annual Meeting & Exhibits
San Jose, CA.
November 17-20, 2010

AMP Member Benefits

Membership Information
Online Member Directory
Web Library
JMD Online
CHAMP Member LISTSERV

How to Help

Volunteer

Highlights

Awards, Grants & Honors
Career Development
Get Involved in AMP
Corporate Support
The Journal of Molecular Diagnostics

Corporate Support Opportunities

Meeting and Event Sponsorships
Exclusive Award Sponsorships
Corporate Partnerships

Committee / Council Member Log-In

Login Portal

 

Renew

AMP Members, click here to pay your 2010 AMP Membership Dues

 

Are you interested in becoming a member of AMP? Click here to join for 2010!

 

News

AMP Responds to Genetic Test Registry Request for Information

Today, the Association for Molecular Pathology (AMP) submitted written comments in response to the Request for Information made by the National Institutes of Health (NIH) for its Genetic Test Registry (GTR). AMP conducted a survey of its membership to formulate a comprehensive response to the RFI. (July 29, 2010)  

>>Download Entire Press Release  >>Download full statement 

 

AMP Presents at FDA Meeting on Regulating Diagnostics

The Association for Molecular Pathology (AMP) participated in the
Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) public meeting on the oversight of laboratory developed tests (LDTs). (July 20, 2010)   >>Download Entire Press Release   >>Download full statement 

 

Comments to FDA CDRH Council regarding barriers to market for molecular diagnostic tests (June 2010 >>Download Statement

 

Comments to SACGHS regarding the draft report on Genetics Education and Training (June 2010 >>Download Statement

 

AMP Commends SACGHS's Whole Genome Sequencing Focus, Raises Ethical Questions and Forms Whole Genome Analysis Working Group (June 15, 2010)  >>Download statement

 

AMP Cautions Consumers About Direct Access Genetic Testing

In response to recent announcements about consumer genetic tests being made available in retail drugstores, the AMP today reiterated its position that these tests should be provided to the public only through the services of appropriate health care professionals that order tests from CLIA-certified laboratories. (May 14, 2010)   >>Download Entire Press Release

 

The Association for Molecular Pathology Celebrates Ruling in DNA Patent Case
The Association for Molecular Pathology (AMP) applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (March 31, 2010)
>>Download Entire Press Release

 

Read the February 2010 issue of the AMP Newsletter, Includes Subdivision and Committee Reports, Annual Meeting Photo Album, and Photo Contest Winners, and Young Investigator, Technologist, and Technologist Travel Awardees

 

AMP comments urge the SACGHS to finalize gene patent report and recommendations as presented in October 2009 (Feb. 4, 2010)

 

AMP's position on the oversight of laboratory developed tests (LDTs) released and discussed with FDA (Jan. 28, 2010)

 

AMP & CAP present a joint statement to MEDCAC regarding pharmacogenomic testing (January 27, 2010).